
Opinion|Podcasts|April 1, 2024
Paradigm Shift in Parkinson’s Disease Diagnosis
Author(s)Stuart H. Isaacson, MD, FAAN, Rajesh Pahwa, MD
Listen
0:00 / 0:00
The neurology experts discuss the importance of early and accurate diagnosis of Parkinson’s disease, the role of alpha-synuclein in the diagnosis of synucleinopathies and approaches to implementing screening protocols in clinical practice.
Advertisement
0:50 Diagnosis of Parkinson’s disease
3:20 Preclinical start of Parkinson’s disease
5:00 Alpha-synuclein in Parkinson’s disease
6:50 Biomarkers in Parkinson’s disease
12:00 Syn-One test for Parkinson’s disease
21:15 Advanced diagnostics in Parkinson’s disease
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
3
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
4
This Week on NeurologyLive® — July 20, 2026
5
















